Recent Headlines
AveXis Inc. Names Director, Scientific and Corporate Affairs
AveXis Inc. (avexisinc.com), a synthetic biology platform company, today announced Mindy Du as the company’s new Director of Scientific and Corporate Affairs. This is an essential position within the company, as AveXis is focused on research/development of leading-edge technology for disease... - September 13, 2013 - AveXis Inc.
NIH Awards Advaita $2.0M for Disease Subtyping and Drug Repurposing Technology Development
The National Institute of General Medical Sciences of the National Institutes of Health issued a Notice of Award granting a Fast-Track Small Business Investigational Research (SBIR) Phase I and Phase II grant of $2.0 million for Advaita Bioinformatics, of Plymouth, Michigan to develop biological... - September 13, 2013 - Advaita
Silicon Kinetics® Ramps Commercial Efforts for Affinity Capture-Mass-Spectrometry (AC-MS)
Appoints Jay Smith as CEO and Keith Waddell as VP Business Development - September 12, 2013 - Silicon Kinetics
SafeStitch Medical Completes Merger with TransEnterix
$30 Million Financing Raised from Existing TransEnterix and SafeStitch Medical Stockholders, Combined Company to be Renamed TransEnterix. - September 06, 2013 - TransEnterix
SFL’s Managing Director Invited to Share Expertise at “Pharma Meets Medtech” Event
SFL's Managing Director offers insights for better pharm and medtech collaboration - September 01, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
CHI Interviews Janet L. Lathey, Ph.D of Emergent BioSolutions on Optimizing Bioassays for Biologics
Janet L. Lathey, Ph.D., Director, Immunology and Assay Development, BioDefense Division, Emergent BioSolutions sits down with conference producer Samantha Lewis to discuss the biggest challenges to managing bioassay variability, new tools and strategies that researchers are using to combat it, and... - August 26, 2013 - Cambridge Healthtech Institute
Creative Biomart Launches Controlled Randomization Service for Random Nucleotide Substitutions
The GenePowerTM Controlled Randomization technology allows you to accurately direct the effective frequency of random nucleotide substitutions. And unlike error-prone PCR, you decide exactly which part(s) of the gene are affected—randomize the entire open reading frame or confine the mutagenesis to specific regions. - August 24, 2013 - Creative Biomart
AveXis Inc. Names Director of Clinical Operations and Research
AveXis Inc. (avexisinc.com), a synthetic biology platform company, today announced Minna Du as the company’s Director of Clinical Operations and Research. This is a critical position within the company, as AveXis is focused on research/development of technology for disease treatment. - August 21, 2013 - AveXis Inc.
Creative Biomart Releases New Antibody Products—Nanobodies
Creative Biomart releases new antibody products, nanobodies, recently. Compared to conventional antibodies, nanobodies also integrate the features of small molecules. - August 18, 2013 - Creative Biomart
MoBiTec GmbH, Germany, is Offering SURE Gene Expression System for Bacillus Subtilis, Regulated by Subtilin
A system for SUbtilin-Regulated gene Expression (SURE) in Bacillus subtilis is offered. Subtilin is a small peptide antibiotic produced by Bacillus subtilis. The SURE system provides an alternative to, e.g., IPTG or xylose inducible systems. - August 17, 2013 - MoBiTec GmbH
Cheers: Researchers Identified New Brain Markers with Creative Biomart’s S100B Antibody
In the study, researchers used the critical products purchased from Creative Biomart. During the process, the serum levels of molecular markers were determined by ELISA using antibodies and antigens from Creative Biomart (New York, NY) (S100B) which you can see in the article. - August 16, 2013 - Creative Biomart
Experts from Creative Biomart Share the Experience on Using Elisa Kits to Improve the Precision of an Assay
There are some issues that researchers might meet in the process of using ELISA Kits. In order to help improve the precision of an assay, Creative Biomart (http://www.creativebiomart.net/) experts concluded the following tips for reference. - August 14, 2013 - Creative Biomart
Research Antibody Survey: Creative Biomart Conducted a Survey Among Antibodies Users
In order to direct market and perfect products, Creative Biomart conducted the survey. And the survey results are listed as follows. - August 03, 2013 - Creative Biomart
AveXis Inc. Names Chief Scientific Officer
AveXis Inc. (avexisinc.com), a synthetic biology platform company focused on research and development of technology for disease treatment, today announced Dr. Allan A. Kaspar will serve as the company’s first Chief Scientific Officer (CSO). Dr. Kaspar has held research positions at multiple... - August 01, 2013 - AveXis Inc.
New Company Formed to Focus on New Technology for Disease Treatment
AveXis Inc. (avexisinc.com) announced its formation as a company focused on research and development of technology specifically for disease treatment. A synthetic biology platform company, AveXis has, at its core, a desire to establish unique industry alliances which will bring innovative... - July 27, 2013 - AveXis Inc.
Final Agenda Announced for CHI’s FAST: Functional Analysis & Screening Technologies Congress
Headlined by Karen Burg, DL Taylor, Steve Ludbrook and Aaron Morris, CHI's FAST Congress features three days of innovative presentations for more accurate biological response in drug discovery through novel screening technologies and strategies. - July 27, 2013 - Cambridge Healthtech Institute
New Research Validates Importance of Central Lab to Overall Investigator Satisfaction
More than 250 Clinical Investigators Indicate Central Lab Preference - July 26, 2013 - Life Science Strategy Group, LLC
OsoBio Appoints Lindsey Pruitt to Manage East Coast Business Development Efforts
Working in her new capacity in OsoBio’s Philadelphia location, Pruitt will identify and foster new business opportunities throughout the Northeast. - July 22, 2013 - OSO BioPharmaceuticals Manufacturing, LLC
Four Insightful Conferences to be Held at CHI's Fifth Annual Immunogenicity Summit 2013
Technologies and Strategies for Safe and Efficacious Products in the Clinic - July 15, 2013 - Cambridge Healthtech Institute
Creative Biomart Launched Novel Animal-free Recombinant Proteins for Stable Research
The novel animal-free protein production system is more efficient, fast, flexible and cheap compared to transgenic plants recombinant proteins production; the scaling-up compared with bio-reactors is simple and lineal. It doesn't have issues with inclusion bodies as E.coli. - June 28, 2013 - Creative Biomart
F2G Ltd and the University of Manchester Announce a New 6.1 Million Euro Project to Develop New Antifungal Agents to Treat Resistant Fungal Infections.
F2G Ltd, a privately-held antifungal drug discovery and development company and The University of Manchester, today announced the commencement of a 6.1 million euro EU-funded project to discover and develop novel antifungal drugs to treat serious, life-threatening fungal infections. The NOFUN... - June 28, 2013 - F2G Ltd
OsoBio Names Kathleen Larese Director of Laboratories
OsoBio has named Kathleen Larese director of laboratories. As part of OsoBio’s quality control department, the microbiology and chemistry laboratories that Larese now directs are responsible for environmental monitoring, analytical method development, and testing all incoming raw materials,... - June 26, 2013 - OSO BioPharmaceuticals Manufacturing, LLC
TransEnterix Develops Patient-Side Robotic Surgical Platform
Company's single-site mobile robot is now undergoing pre-clinical testing. - June 26, 2013 - TransEnterix
MD Stem Cells Shows Retinal Eye Disease Responds to Stem Cells with Significant Vision Improvement
Blinding retinal eye disease called Retinitis Pigmentosa seen to make major gains in visual acuity following adult stem cell therapy in the United States. - June 20, 2013 - MD Stem Cells
NanCogenics Reports Research Findings on Tumor-Localization of Cancer Therapeutics
Research results on the use of magnetic nanovectors for the tumor-specific localization of cancer therapeutics is discussed. - June 08, 2013 - NanCogenics Inc
CovalX and Bruker Daltonics Announce Strategic Collaboration in High Mass MALDI Detection
Joint Support of CovalX High Mass Detection Systems for all Bruker autoflex and ultraflex series instruments worldwide will provide new and existing Bruker MALDI customers with access to CovalX applications for protein interaction and macromolecular analysis. - June 07, 2013 - CovalX
MoBiTec GmbH and Bachem Americas, Inc., Sign Distribution Agreement for the European Market
MoBiTec GmbH, a Germany based biotech company focused on products for life science research, has entered into a distribution agreement with Bachem Americas, Inc., USA. Together with Bachem Americas, MoBiTec will continue to expand its portfolio of premier brands and high-quality products through the addition of Bachem’s high-quality immunology products. - June 01, 2013 - MoBiTec GmbH
Creative Biomart Scientists Found That Shutdown Gene Arih2 May Treat Hepatitis
Arih2 was found within the sentinel dendritic cells of the immune system, which play a vital role in defending intruders. - May 31, 2013 - Creative Biomart
Tucson Surgeon First in State to Offer SPIDER Gastric Sleeve for Weight Loss
Dr. Patrick Chiasson at Southern Arizona Center for Minimally Invasive Surgery also uses novel single-incision surgical platform for gallbladder removal. - May 30, 2013 - TransEnterix
Coral Products Launch Kitchen Caddy with SteriTouch®
Merseyside-based Coral Products plc has introduced an antimicrobial food recycling bin to its range of products supplied to local authorities, and is confident that this development will encourage the use of food caddies in the home. Incorporating SteriTouch® universal masterbatch into the... - May 30, 2013 - SteriTouch Ltd
MiTeGen Announces Collaboration and License Agreements with EMBL
MiTeGen LLC, a provider of innovative consumables for X-ray diffraction, crystallography and protein crystallization to academic, pharmaceutical, industrial and government researchers around the world, announced that it has signed agreements with EMBLEM, the commercial subsidiary of the EMBL (the... - May 23, 2013 - MiTeGen, LLC
Md Stem Cells Continues Billion Cell Treatments for Eye Disease
MD Stem Cells Reports Billion Cell Harvests for Eye Stem Cell Treatments in Florida. - May 11, 2013 - MD Stem Cells
OsoBio Appoints David M. Lee Vice President of Quality
OsoBio has named David M. Lee vice president of quality. Lee is responsible for overseeing all quality-related functions to ensure the company’s continued compliance with Current Good Manufacturing Practices (cGMP), including quality systems, quality control and manufacturing quality... - May 10, 2013 - OSO BioPharmaceuticals Manufacturing, LLC
Creative BioMart Funded Research Found Another Anticancer Strategy - Targeting Cyclin D
Researchers successfully silenced abnormal proteins that control cells' growth cycle. - May 10, 2013 - Creative Biomart
Herpes Solution Provider, Viradux Research Announces JV Partnership
A new development in the war against genital and oral herpes. - April 26, 2013 - viradux
YaxinBio Launches 2 New Products: Enterokinase and V8 Protease
Shanghai Yaxin Biotechnology Co., Ltd. offers two new recombinant proteins. Recombinant Bovine enterokinase, also known as enteropeptidase, is a specific protease used for tag removal, while V8 Protease (Endoproteinase GluC) is highly important for protein structure and sequence... - April 23, 2013 - Shanghai Yaxin Biotechnology Co. Ltd.
Eye Doctor Finds Impressive Vision Improvements from Stem Cell Treatment Reports MD Stem Cells
Post-operative visual acuity significantly improved following stem cell treatment for Macular Degeneration according to an independent Optometrist in California. - April 12, 2013 - MD Stem Cells
Virtual Model of Novel Cancer Target Developed
Plebiotic and Pharmacellion Complete Research Project on an in silico Molecular Modelling and Molecular Dynamics Model of Na K ATPase. - April 12, 2013 - Ventac Partners
Houston Bariatric Practice Hits Surgery Milestone: 100th SPIDER ® Sleeve
Gastric sleeve weight-loss surgery patients report satisfaction with lack of visible scars, recovery and comfort. - April 10, 2013 - TransEnterix
MD Stem Cells - Macular Degeneration Patient Continues to Improve Following Stem Cell Treatments
Married for 72 years, patient’s husband confirms positive visual results are continuing for his wife following stem cell treatment for AMD. - March 23, 2013 - MD Stem Cells
SFL Appoints Advisory Board
SFL announces details of its Advisory Board. - March 22, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
F2G Ltd Appoints Ian Nicholson as Chief Executive Officer
F2G Ltd, the UK-based antifungal drug discovery and development company, today announced the appointment of Ian Nicholson to the position of CEO and to the Board of Directors. - March 20, 2013 - F2G Ltd
Arbovax Completes Successful Pre-Clinical Trial of Tetravalent Dengue Vaccine
Successful Pre-Clinical Tests Support Vaccine Platform, New Injection Protocol - March 19, 2013 - Arbovax Inc
Promoters for Improved Protein & Biopharmaceutics Production in Mammalian Cells
Synpromics Ltd, the synthetic promoter company, announces the award by the Technology Strategy Board, the UK’s innovation agency, of an over £240,000 grant under the TSB’s Synthetic Biology initiative to a consortium led by Synpromics and also including Genabler Ltd and the University of Edinburgh’s SynthSys Centre for Synthetic and Systems Biology. - March 09, 2013 - Synpromics Ltd
MMS Set to Expand Disclosure Services with Registry Reporting Software TrialAssure™
MMS Holdings Inc. today announced that it has successfully executed disclosure management services for several clients and is poised to make strides in this area with its proprietary software, TrialAssure™. TrialAssure™ is a workflow management system that supports the reporting of... - March 02, 2013 - MMS Holdings Inc.
SFL Experts to Present and Chair Sessions at the 2013 DIA Annual EuroMeeting
SFL team showcase expertise in Regulatory Affairs, Public Affairs, Legal Services and Medical Communications at DIA EuroMeeting in Amsterdam. - March 01, 2013 - SFL Regulatory Affairs & Scientific Communication Ltd
Ohio State and Biosortia Pharmaceuticals to Join Forces to Discover Anti-Cancer Compounds
The Ohio State University has signed an agreement with Biosortia Pharmaceuticals of Dublin, Ohio to discover new biologically active natural products with potential anti-cancer activity. Potential candidate compounds discovered during the Biosortia-sponsored research project will primarily be tested against human colon cancer assays. The ultimate goal is to obtain lead compounds that can be licensed to and developed by pharmaceutical companies through Biosortia’s pharmaceutical relationships. - February 28, 2013 - Biosortia Pharmaceuticals
OsoBio President to Join Injectable Trends Discussion at DCAT Week
OsoBio President Milton Boyer and other experts will examine industry's shortages. - February 22, 2013 - OSO BioPharmaceuticals Manufacturing, LLC
MD Stem Cells: Very Elderly Benefit from Stem Cells for Macular Degeneration
92 year old shows rapid vision results with stem cells. Age is not a barrier to visual improvement following stem cell treatment reports MD Stem Cells. - February 21, 2013 - MD Stem Cells
Cambridge Healthtech Institute & Bio-IT World Announces Program for Its 13th Annual Structure-Based Drug Design Conference, June 19-21, 2013, Boston, MA
Featuring Keynote from Aileron Therapeutics’ Tomi Sawyer - February 16, 2013 - Cambridge Healthtech Institute